FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology. The maximum corrected visual acuity, time when first complaints are appeared, as well as criteria of structural optical coherence tomography are determined: hyperreflectivity of choroidal vessels, presence of photoreceptors erosion and massive subretinal deposits. Then the probability (B) of the patient having central serous chorioretinopathy and vitelliform dystrophies is calculated according to the original formula. With B from 0.5 to 1.0, a conclusion is made about the probable presence of vitelliform dystrophy in patient. With B from 0.0 to 0.49 - probable presence of chronic central serous chorioretinopathy.
EFFECT: method allows optimizing the differential diagnosis of chronic central serous chorioretinopathy and vitelliform dystrophy in adult patients.
1 cl, 2 tbl, 3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MULTIMODAL DIFFERENTIAL DIAGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND VITELLIFORM DYSTROPHIES IN ADULT PATIENTS | 2021 |
|
RU2765015C1 |
METHOD FOR MULTIMODAL DIFFERENTIAL DIAGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND VITELLIFORM DYSTROPHIES | 2021 |
|
RU2765014C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND VITELLIFORM DYSTROPHIES | 2021 |
|
RU2765016C1 |
METHOD OF PREDICTING THE PRESENCE OF CHORIOCAPILLARY PATHOLOGY IN THE PROJECTION OF THE MACULAR AREA IN CHRONIC MYELOPROLIFERATIVE DISEASES | 2022 |
|
RU2798930C1 |
METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
METHOD OF CENTRAL SEROUS CHORIORETINOPATHY TREATMENT | 2022 |
|
RU2797276C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF MYOPIC CHOROIDAL NEOVASCULARIZATION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN MYOPIC EYES | 2020 |
|
RU2749120C1 |
METHOD FOR DETERMINING THE TACTICS OF LASER TREATMENT OF ACUTE AND CHRONIC CENTRAL SEROUS CHORIORETINOPATHY | 2018 |
|
RU2674382C1 |
METHOD OF DETECTING RETINAL PATHOLOGY | 2022 |
|
RU2802558C1 |
METHOD OF DETERMINING INDICATIONS FOR PHOTODYNAMIC THERAPY OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY | 2012 |
|
RU2495620C1 |
Authors
Dates
2021-11-01—Published
2021-05-21—Filed